Related Experiment Video
Updated: May 11, 2026

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Post-PKS tailoring steps of the spiramycin macrolactone ring in Streptomyces ambofaciens
Hoang-Chuong Nguyen1, Emmanuelle Darbon, Robert Thai
1Université Paris-Sud, Institut de Génétique et Microbiologie, UMR 8621, Orsay, France.
Abstract:
Spiramycins are clinically important 16-member macrolide antibiotics produced by Streptomyces ambofaciens. Biosynthetic studies have established that the earliest lactonic intermediate in spiramycin biosynthesis, the macrolactone platenolide I, is synthesized by a type I modular polyketide synthase (PKS). Platenolide I then undergoes a series of post-PKS tailoring reactions yielding the final products, spiramycins I, II, and III. We recently characterized the post-PKS glycosylation steps of spiramycin biosynthesis in S. ambofaciens. We showed that three glycosyltransferases, Srm5, Srm29, and Srm38, catalyze the successive attachment of the three carbohydrates mycaminose, forosamine, and mycarose, respectively, with the help of two auxiliary proteins, Srm6 and Srm28. However, the enzymes responsible for the other tailoring steps, namely, the C-19 methyl group oxidation, the C-9 keto group reduction, and the C-3 hydroxyl group acylation, as well as the timing of the post-PKS tailoring reactions, remained to be established. In this study, we show that Srm13, a cytochrome P450, catalyzes the oxidation of the C-19 methyl group into a formyl group and that Srm26 catalyzes the reduction of the C-9 keto group, and we propose a timeline for spiramycin-biosynthetic post-PKS tailoring reactions.
Insights
This study identifies key enzymes Srm13 and Srm26 involved in spiramycin antibiotic biosynthesis. It also proposes a timeline for the post-polyketide synthase tailoring reactions, advancing our understanding of macrolide antibiotic production.
Area of Science:
- Microbiology
- Biochemistry
- Molecular Biology
Background:
- Spiramycins are crucial 16-member macrolide antibiotics produced by Streptomyces ambofaciens.
- Biosynthesis involves a type I modular polyketide synthase (PKS) forming platenolide I, followed by post-PKS modifications.
Purpose of the Study:
- To identify enzymes responsible for C-19 methyl oxidation and C-9 keto reduction in spiramycin biosynthesis.
- To establish the timing of post-PKS tailoring reactions in spiramycin production.
Main Methods:
- Enzyme characterization
- Biochemical assays
- Genetic analysis of Streptomyces ambofaciens
Main Results:
- Srm13, a cytochrome P450, was identified as catalyzing C-19 methyl group oxidation to a formyl group.
- Srm26 was identified as catalyzing the reduction of the C-9 keto group.
- A proposed timeline for the post-PKS tailoring reactions was established.
Conclusions:
- The study elucidates key enzymatic steps and the sequence of post-PKS modifications in spiramycin biosynthesis.
- This work contributes to a comprehensive understanding of macrolide antibiotic production pathways.
More Related Videos
10:41The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
Published on: January 13, 2013
07:59A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019